Wesley Hoffmann
Pharmacist
6565 Fannin St, Houston
Texas, 77030-2703
719-790-3311 Wesley Hoffmann is a pharmacist in Houston, Texas. Patients can reach him at 6565 Fannin St, Houston or contact him on 719-790-3311. Active license number of Wesley Hoffmann is 71999 for Pharmacist in Texas.
Wesley Hoffmann is
Complete Profile:
Wesley Hoffmann speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
| Name: | Wesley Hoffmann |
| Specialization: | Pharmacist |
| Credentials: | PHARMD |
| Gender: | Male |
| Location: | 6565 Fannin St, Houston,
Texas, 77030-2703 |
| Phone: | 719-790-3311 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Wesley Hoffmann are as mentioned below.
| NPI Number: | 1548007743 |
| NPI Enumeration Date: | 15 Jul, 2024 |
| NPI Last Update On: | 15 Jul, 2024 |
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Wesley Hoffmann are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacist | 71999 | Texas | Primary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 6565 Fannin St,
Houston, Texas |
| Zip: | 77030-2703 |
| Phone Number: | -- |
Patients can reach Wesley Hoffmann at
6565 Fannin St, Houston, Texas or can
call on phone at 719-790-3311.
Comments/ Reviews:
Read all the reviews posted for Wesley Hoffmann below. You may also share your own experience with Wesley Hoffmann. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.